carbidopa has been researched along with Growth Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Vries, T; Garbis-Berkvens, JM; Peters, PW; Rauws, AG; van Logten, MJ; Vos, JG | 1 |
Grimm, W; Koffler, T; Philippi, H; Pohlenz, J; Schönberger, W | 1 |
Brodt, B; Grimm, W; Schönberger, W; Ziegler, R | 1 |
3 other study(ies) available for carbidopa and Growth Disorders
Article | Year |
---|---|
Comparative 90-day toxicity of two decarboxylase inhibitors, benserazide and carbidopa, in the rat.
Topics: Animals; Benserazide; Blood; Bone and Bones; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Eating; Female; Growth Disorders; Hydrazines; Male; Organ Size; Radiography; Rats; Rats, Inbred Strains | 1982 |
Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature.
Topics: Adolescent; Adrenocorticotropic Hormone; Carbidopa; Child; Child, Preschool; Dopamine Agents; Drug Synergism; Female; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Pituitary Function Tests; Propranolol | 2000 |
[Stimulation of the secretion of somatotropin by administration of Nacom (L-dopa and L-carbidopa) in ambulatory patients with retarded growth].
Topics: Adolescent; Ambulatory Care; Carbidopa; Child; Drug Combinations; Growth Disorders; Growth Hormone; Humans; Hydrazines; Levodopa | 1977 |